Harmony Biosciences Holdings Inc (NAS:HRMY)
$ 29.95 0.6 (2.04%) Market Cap: 1.70 Bil Enterprise Value: 1.52 Bil PE Ratio: 12.97 PB Ratio: 3.30 GF Score: 63/100

Q3 2020 Harmony Biosciences Holdings Inc Earnings Call Transcript

Nov 12, 2020 / 01:30PM GMT
Release Date Price: $43.94 (-7.44%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Harmony Third Quarter 2020 Financial Update Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Lisa Caperelli, Associate Vice President, Investor Relations. Please go ahead, ma'am.

Lisa M. Caperelli
Harmony Biosciences Holdings, Inc. - Head of IR

Thank you, Josh. Good morning, everyone, and thank you for joining us today as we review Harmony's third quarter 2020 performance and provide business updates. Our presenters on today's call are our CEO, John Jacobs; Chief Medical Officer, Dr. Jeffrey Dayno; our Chief Commercial Officer, Jeffrey Dierks; and our CFO, Susan Drexler. The slides that will be presented on this call can be viewed in the Investors section on our website at harmonybiosciences.com.

Before we start, I would like to remind you that our discussions during this conference call will include forward-looking statements. All

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot